Enbrel 50 MG/ML mini cartridgeml
Ended Awarded Last action
- Contract number
- SPE2DR26FX4B3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,193
Award facts
- Contract value 100% obligated
- $44,192.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Enbrel 50 mg/ml mini cartridges, with a ceiling value of $44,192.73 and a completion date of January 5, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. Enbrel is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions, reflecting the company's role in supplying specialty pharmaceuticals to support military healthcare requirements through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26FX4B3?
SPE2DR26FX4B3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FX4B3 worth?
The government has obligated $44,193 on SPE2DR26FX4B3.
Is contract SPE2DR26FX4B3 an order under another contract?
Yes. SPE2DR26FX4B3 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4B3 competed?
The extent of competition for SPE2DR26FX4B3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award